Literature DB >> 32097504

Association Between Recurrent Fracture Risk and Implementation of Fracture Liaison Services in Four Swedish Hospitals: A Cohort Study.

Kristian F Axelsson1,2, Helena Johansson3, Dan Lundh4, Michael Möller5,6, Mattias Lorentzon2,3,7.   

Abstract

Structured secondary preventions programs, called fracture liaison services (FLSs), increase the rate of evaluation with bone densitometry and use of osteoporosis medication after fracture. However, the evidence regarding the effect on the risk of recurrent fracture is insufficient. The aim of this study was to investigate if implementation of FLS was associated with reduced risk of recurrent fractures. In this retrospective cohort study, electronic health records during 2012 to 2017 were used to identify a total of 21,083 patients from four hospitals in Western Sweden, two with FLS (n = 15,449) and two without (n = 5634). All patients aged 50 years or older (mean age 73.9 [SD 12.4] years, 76% women) with a major osteoporotic index fracture (hip, clinical spine, humerus, radius, and pelvis) were included. The primary outcome was recurrent major osteoporotic fracture. All patients with an index fracture during the FLS period (n = 13,946) were compared with all patients in the period before FLS implementation (n = 7137) in an intention-to-treat analysis. Time periods corresponding to the FLS hospitals were used for the non-FLS hospitals. In the hospitals with FLSs, there were 1247 recurrent fractures during a median follow-up time of 2.2 years (range 0-6 years). In an unadjusted Cox model, the risk of recurrent fracture was 18% lower in the FLS period compared with the control period (hazard ratio = 0.82, 95% confidence interval [CI] 0.73-0.92, p = .001), corresponding to a 3-year number needed to screen of 61, and did not change after adjustment for clinical risk factors. In the hospitals without FLSs, no change in recurrent fracture rate was observed. Treatment decisions were made according to the Swedish treatment guidelines. In conclusion, implementation of FLS was associated with a reduced risk of recurrent fracture, indicating that FLSs should be included routinely at hospitals treating fracture patients.
© 2020 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research. © 2020 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research.

Entities:  

Keywords:  FRACTURE; FRACTURE LIAISON SERVICE; OSTEOPOROSIS; RECURRENT FRACTURE

Mesh:

Year:  2020        PMID: 32097504     DOI: 10.1002/jbmr.3990

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  12 in total

1.  Patients 80 + have similar medication initiation rates to those aged 50-79 in Ontario FLS.

Authors:  J E M Sale; A Yang; V Elliot-Gibson; R Jain; R Sujic; D Linton; J Weldon; L Frankel; E Bogoch
Journal:  Osteoporos Int       Date:  2021-01-20       Impact factor: 4.507

2.  Population screening for fracture risk in postmenopausal women - a logical step in reducing the osteoporotic fracture burden?

Authors:  E V McCloskey; P Chotiyarnwong; N C Harvey; M Lorentzon; J A Kanis
Journal:  Osteoporos Int       Date:  2022-06-28       Impact factor: 5.071

3.  Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.

Authors:  P Chotiyarnwong; E V McCloskey; N C Harvey; M Lorentzon; D Prieto-Alhambra; B Abrahamsen; J D Adachi; F Borgström; O Bruyere; J J Carey; P Clark; C Cooper; E M Curtis; E Dennison; M Diaz-Curiel; H P Dimai; D Grigorie; M Hiligsmann; P Khashayar; E M Lewiecki; P Lips; R S Lorenc; S Ortolani; A Papaioannou; S Silverman; M Sosa; P Szulc; K A Ward; N Yoshimura; J A Kanis
Journal:  Arch Osteoporos       Date:  2022-06-28       Impact factor: 2.879

Review 4.  UK clinical guideline for the prevention and treatment of osteoporosis.

Authors:  Celia L Gregson; David J Armstrong; Jean Bowden; Cyrus Cooper; John Edwards; Neil J L Gittoes; Nicholas Harvey; John Kanis; Sarah Leyland; Rebecca Low; Eugene McCloskey; Katie Moss; Jane Parker; Zoe Paskins; Kenneth Poole; David M Reid; Mike Stone; Julia Thomson; Nic Vine; Juliet Compston
Journal:  Arch Osteoporos       Date:  2022-04-05       Impact factor: 2.879

Review 5.  Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance.

Authors:  G Hampson; M Stone; J R Lindsay; R K Crowley; S H Ralston
Journal:  Calcif Tissue Int       Date:  2021-05-18       Impact factor: 4.333

6.  The Swedish Fracture Register - ten years of experience and 600,000 fractures collected in a National Quality Register.

Authors:  Michael Möller; Olof Wolf; Carl Bergdahl; Sebastian Mukka; Emilia Möller Rydberg; Nils P Hailer; Jan Ekelund; David Wennergren
Journal:  BMC Musculoskelet Disord       Date:  2022-02-11       Impact factor: 2.362

Review 7.  The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis.

Authors:  N Li; M Hiligsmann; A Boonen; M M van Oostwaard; R T A L de Bot; C E Wyers; S P G Bours; J P van den Bergh
Journal:  Osteoporos Int       Date:  2021-04-07       Impact factor: 4.507

Review 8.  State of Fragility Fractures Management during the COVID-19 Pandemic.

Authors:  Umberto Tarantino; Ida Cariati; Virginia Tancredi; Donato Casamassima; Eleonora Piccirilli; Riccardo Iundusi; Elena Gasbarra
Journal:  Int J Environ Res Public Health       Date:  2020-10-22       Impact factor: 3.390

Review 9.  Efficacy and efficiency of fracture liaison services to reduce the risk of recurrent osteoporotic fractures.

Authors:  M K Javaid
Journal:  Aging Clin Exp Res       Date:  2021-05-28       Impact factor: 3.636

10.  The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications.

Authors:  M K Skjødt; M T Ernst; S Khalid; C Libanati; C Cooper; A Delmestri; K H Rubin; M K Javaid; D Martinez-Laguna; E Toth; D Prieto-Alhambra; B Abrahamsen
Journal:  Osteoporos Int       Date:  2021-03-15       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.